Sn. Leech et al., Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1, J CLIN PATH, 54(9), 2001, pp. 727-729
Citations number
10
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Aim-To investigate whether immunohistochemical staining for cytokeratin 20
(CK20) and thyroid transcription factor I (TTF-1) is useful in distinguishi
ng Merkel cell carcinomas (MCCs) from metastatic small cell carcinomas (SCC
s).
Methods-Eleven cases of MCC and 10 of lung SCC were stained for CK20 and TT
F-1.
Results-Ten of I I MCCs stained with the antibody to CK20. None was positiv
e for TTF-1. No SCC stained with anti-CK20 and all stained strongly with an
ti-TTF-1.
Conclusions-The use of both anti-CK20 and anti-TTF-1 can reliably distingui
sh between MCC and metastatic SCC, thus avoiding the need for a detailed cl
inical investigation of patients with MCC in whom metastatic SCC must be ex
cluded.